PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ARDX vs. PACB
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


ARDXPACB
YTD Return-5.00%-74.41%
1Y Return46.52%-65.24%
3Y Return (Ann)70.43%-56.04%
5Y Return (Ann)2.73%-12.31%
10Y Return (Ann)-12.95%-9.13%
Sharpe Ratio0.60-0.53
Sortino Ratio1.38-0.28
Omega Ratio1.190.96
Calmar Ratio0.53-0.63
Martin Ratio1.68-0.91
Ulcer Index27.95%67.89%
Daily Std Dev78.85%115.72%
Max Drawdown-98.45%-97.65%
Current Drawdown-82.09%-95.09%

Fundamentals


ARDXPACB
Market Cap$1.44B$684.05M
EPS-$0.27-$1.55
PEG Ratio-0.08-0.17
Total Revenue (TTM)$251.85M$133.18M
Gross Profit (TTM)$215.19M$19.12M
EBITDA (TTM)-$60.37M-$206.13M

Correlation

-0.50.00.51.00.3

The correlation between ARDX and PACB is 0.27, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

ARDX vs. PACB - Performance Comparison

In the year-to-date period, ARDX achieves a -5.00% return, which is significantly higher than PACB's -74.41% return. Over the past 10 years, ARDX has underperformed PACB with an annualized return of -12.95%, while PACB has yielded a comparatively higher -9.13% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-40.00%-20.00%0.00%20.00%40.00%JuneJulyAugustSeptemberOctoberNovember
-36.74%
34.20%
ARDX
PACB

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ARDX vs. PACB - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Ardelyx, Inc. (ARDX) and Pacific Biosciences of California, Inc. (PACB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


ARDX
Sharpe ratio
The chart of Sharpe ratio for ARDX, currently valued at 0.60, compared to the broader market-4.00-2.000.002.000.60
Sortino ratio
The chart of Sortino ratio for ARDX, currently valued at 1.38, compared to the broader market-4.00-2.000.002.004.001.38
Omega ratio
The chart of Omega ratio for ARDX, currently valued at 1.19, compared to the broader market0.501.001.502.001.19
Calmar ratio
The chart of Calmar ratio for ARDX, currently valued at 0.53, compared to the broader market0.002.004.006.000.53
Martin ratio
The chart of Martin ratio for ARDX, currently valued at 1.68, compared to the broader market-10.000.0010.0020.0030.001.68
PACB
Sharpe ratio
The chart of Sharpe ratio for PACB, currently valued at -0.53, compared to the broader market-4.00-2.000.002.00-0.53
Sortino ratio
The chart of Sortino ratio for PACB, currently valued at -0.28, compared to the broader market-4.00-2.000.002.004.00-0.28
Omega ratio
The chart of Omega ratio for PACB, currently valued at 0.96, compared to the broader market0.501.001.502.000.96
Calmar ratio
The chart of Calmar ratio for PACB, currently valued at -0.63, compared to the broader market0.002.004.006.00-0.63
Martin ratio
The chart of Martin ratio for PACB, currently valued at -0.91, compared to the broader market-10.000.0010.0020.0030.00-0.91

ARDX vs. PACB - Sharpe Ratio Comparison

The current ARDX Sharpe Ratio is 0.60, which is higher than the PACB Sharpe Ratio of -0.53. The chart below compares the historical Sharpe Ratios of ARDX and PACB, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.001.50JuneJulyAugustSeptemberOctoberNovember
0.60
-0.53
ARDX
PACB

Dividends

ARDX vs. PACB - Dividend Comparison

Neither ARDX nor PACB has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

ARDX vs. PACB - Drawdown Comparison

The maximum ARDX drawdown since its inception was -98.45%, roughly equal to the maximum PACB drawdown of -97.65%. Use the drawdown chart below to compare losses from any high point for ARDX and PACB. For additional features, visit the drawdowns tool.


-95.00%-90.00%-85.00%-80.00%-75.00%-70.00%JuneJulyAugustSeptemberOctoberNovember
-82.09%
-95.09%
ARDX
PACB

Volatility

ARDX vs. PACB - Volatility Comparison

The current volatility for Ardelyx, Inc. (ARDX) is 14.72%, while Pacific Biosciences of California, Inc. (PACB) has a volatility of 33.42%. This indicates that ARDX experiences smaller price fluctuations and is considered to be less risky than PACB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%20.00%30.00%40.00%50.00%60.00%70.00%80.00%JuneJulyAugustSeptemberOctoberNovember
14.72%
33.42%
ARDX
PACB

Financials

ARDX vs. PACB - Financials Comparison

This section allows you to compare key financial metrics between Ardelyx, Inc. and Pacific Biosciences of California, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items